• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • Cutting Edge Tech Developments in China

Cutting Edge Tech Developments in China

Friday, 21 August 2020 / Published in Medical Device, News

Cutting Edge Tech Developments in China

The “Artificial Intelligent Medical Device Innovation and Cooperation Platform” was established in July 2019 as a subordinate unit under the CMDE (Center for Medical Device Evaluation) of NMPA (National Medical Products Administration). The CMDE announced their recent developments on July 30, 2020:

Online public service platform (pilot phase) and database for the performance evaluation of AI medical devices

  • The online platform is currently available only for the performance evaluation of AI medical devices detecting diabetic retinopathy in conventional colour fundus photography.
  • The online platform provides access to a database of real-world data collected from 8 provinces, equivalent to 15,000 photographs of the eye fundus (including different retinopathy types, after laser surgery conditions, and low-quality image references).
  • The database can form into sub databases according to the different intended use of AI softwares to determine:
    • The type of diabetic retinopathy
    • The photo quality of the eye fundus
    • The need for hospital transfer

The performance index and testing methods for AI medical devices

Currently only available for AI medical devices:

  • detecting diabetic retinopathy in conventional colour fundus photography; and
  • detecting lung nodules in chest CT scans

The performance index and testing methods serve as a guideline for the “Artificial Intelligent Medical Device Innovation and Cooperation Platform” in their future developments of the AI medical device field.

By Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: AI medical devices

What you can read next

China catalogue import export endangered species
China’s Catalogue for the Import and Export of Endangered Species has been issued.
Extensive additions for CCC and EX in China as of October 1st, 2019
China Implements Trial Version of Real-World Data Guidelines

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.